Andrzej Czyrski

622 total citations
31 papers, 477 citations indexed

About

Andrzej Czyrski is a scholar working on Pharmacology, Molecular Biology and Analytical Chemistry. According to data from OpenAlex, Andrzej Czyrski has authored 31 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 10 papers in Molecular Biology and 9 papers in Analytical Chemistry. Recurrent topics in Andrzej Czyrski's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Analytical Chemistry and Chromatography (7 papers) and Analytical Methods in Pharmaceuticals (7 papers). Andrzej Czyrski is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Analytical Chemistry and Chromatography (7 papers) and Analytical Methods in Pharmaceuticals (7 papers). Andrzej Czyrski collaborates with scholars based in Poland, Germany and United States. Andrzej Czyrski's co-authors include Edyta Szałek, Artur Tężyk, Franciszek K. Główka, Ulrich Girreser, Edmund Grześkowiak, Błażej Rubiś, Mariusz Kaczmarek, Maria Rybczyńska, Bernard Juskowiak and Marta Karaźniewicz‐Łada and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Andrzej Czyrski

28 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrzej Czyrski Poland 14 116 93 84 81 55 31 477
Daksha Desai‐Krieger United States 12 93 0.8× 105 1.1× 64 0.8× 121 1.5× 79 1.4× 12 508
Muhammad Nadeem Asghar Pakistan 16 70 0.6× 155 1.7× 53 0.6× 66 0.8× 76 1.4× 59 646
Keith E. Anderson Canada 9 175 1.5× 152 1.6× 55 0.7× 68 0.8× 48 0.9× 18 807
Taijun Hang China 17 140 1.2× 340 3.7× 76 0.9× 122 1.5× 45 0.8× 71 863
Marcela Cristina de Moraes Brazil 18 107 0.9× 349 3.8× 87 1.0× 78 1.0× 106 1.9× 54 718
Audrey Solgadi France 16 45 0.4× 233 2.5× 75 0.9× 66 0.8× 56 1.0× 45 734
Noha N. Atia Egypt 15 125 1.1× 125 1.3× 215 2.6× 269 3.3× 34 0.6× 57 666
Ande Ma China 13 42 0.4× 110 1.2× 78 0.9× 91 1.1× 31 0.6× 38 500
M. Himaja India 14 57 0.5× 132 1.4× 34 0.4× 48 0.6× 97 1.8× 56 563
Anthony Cartwright United States 11 49 0.4× 65 0.7× 51 0.6× 59 0.7× 36 0.7× 27 512

Countries citing papers authored by Andrzej Czyrski

Since Specialization
Citations

This map shows the geographic impact of Andrzej Czyrski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrzej Czyrski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrzej Czyrski more than expected).

Fields of papers citing papers by Andrzej Czyrski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrzej Czyrski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrzej Czyrski. The network helps show where Andrzej Czyrski may publish in the future.

Co-authorship network of co-authors of Andrzej Czyrski

This figure shows the co-authorship network connecting the top 25 collaborators of Andrzej Czyrski. A scholar is included among the top collaborators of Andrzej Czyrski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrzej Czyrski. Andrzej Czyrski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Czyrski, Andrzej, et al.. (2025). The application of design of experiments and artificial neural networks in the evaluation of the impact of acidic conditions on cloud point extraction. Journal of Chromatography A. 1743. 465686–465686. 1 indexed citations
2.
Czyrski, Andrzej, et al.. (2025). Cloud Point Extraction as an Environmentally Friendly Technique for Sample Preparation. Processes. 13(2). 430–430. 2 indexed citations
3.
Czyrski, Andrzej, et al.. (2025). Saliva as a matrix for therapeutic drug monitoring and disease biomarkers in children and adolescents. Pharmacological Reports. 77(4). 921–961.
4.
Czyrski, Andrzej, et al.. (2024). Design of experiments and artificial neural networks as useful tools in the optimization of analytical procedure. PubMed. 54(2). 113–116. 2 indexed citations
6.
Czyrski, Andrzej, et al.. (2024). Analytical Methods for Determining Psychoactive Substances in Various Matrices: A Review. Critical Reviews in Analytical Chemistry. 56(1). 76–102. 1 indexed citations
7.
Szałek, Edyta, et al.. (2024). Pharmacokinetic interaction between regorafenib and atorvastatin in rats. Pharmacological Reports. 76(5). 1184–1195. 2 indexed citations
8.
Szałek, Edyta, et al.. (2024). Analysis of glycemia during olaparib therapy in patients with ovarian cancer.. Journal of Clinical Oncology. 42(16_suppl). e17559–e17559.
9.
Czyrski, Andrzej, et al.. (2024). The Determination of LogP of Anticoagulant Drugs with High-Performance Thin-Layer Chromatography. Processes. 12(8). 1599–1599. 1 indexed citations
10.
Czyrski, Andrzej, et al.. (2021). Recent Advances in Therapeutic Drug Monitoring of Voriconazole, Mycophenolic Acid, and Vancomycin: A Literature Review of Pediatric Studies. Pharmaceutics. 13(12). 1991–1991. 21 indexed citations
11.
Czyrski, Andrzej. (2021). The spectrophotometric determination of lipophilicity and dissociation constants of ciprofloxacin and levofloxacin. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 265. 120343–120343. 31 indexed citations
12.
Czyrski, Andrzej, et al.. (2019). The degradation of levofloxacin in infusions exposed to daylight with an identification of a degradation product with HPLC-MS. Scientific Reports. 9(1). 3621–3621. 32 indexed citations
13.
Czyrski, Andrzej, et al.. (2019). The application of Box-Behnken-Design in the optimization of HPLC separation of fluoroquinolones. Scientific Reports. 9(1). 19458–19458. 84 indexed citations
14.
Czyrski, Andrzej, et al.. (2018). Determination of gliclazide minimum concentration in type 2 diabetes mellitus patients. Biomedicine & Pharmacotherapy. 106. 1267–1270. 5 indexed citations
15.
Czyrski, Andrzej, et al.. (2017). HPLC method for determination of moxifloxacin in plasma and its application in pharmacokinetic analysis. Journal of Liquid Chromatography & Related Technologies. 40(1). 8–12. 16 indexed citations
16.
Czyrski, Andrzej. (2016). Analytical Methods for Determining Third and Fourth Generation Fluoroquinolones: A Review. Chromatographia. 80(2). 181–200. 32 indexed citations
17.
Czyrski, Andrzej, et al.. (2014). The pharmacokinetic interaction between levofloxacin and sunitinib. Pharmacological Reports. 67(3). 542–544. 13 indexed citations
18.
Czyrski, Andrzej, et al.. (2011). Optimization of a new isoquinoline derivative preparation. Reaction Kinetics Mechanisms and Catalysis. 104(1). 173–180. 1 indexed citations
19.
Girreser, Ulrich, et al.. (2009). Synthesis and structure elucidation of a new isoquinolinium inner salt. Tetrahedron Letters. 50(32). 4610–4612. 8 indexed citations
20.
Rubiś, Błażej, et al.. (2008). The biological activity of G-quadruplex DNA binding papaverine-derived ligand in breast cancer cells. Investigational New Drugs. 27(4). 289–296. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026